scholarly journals Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease

2016 ◽  
Vol 13 (9) ◽  
pp. 1490-1496 ◽  
Author(s):  
Anne C. Melzer ◽  
Laura C. Feemster ◽  
Kristina Crothers ◽  
Shannon S. Carson ◽  
Suzanne E. Gillespie ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
At Risk ◽  
Pulmonary Disease ◽  
Intention To Quit ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Quit Smoking

scholarly journals Chronic Obstructive Pulmonary Disease Combined With Interstitial Lung Disease

2021 ◽  
Author(s):  
Joon Young Choi ◽  
Jin Woo Song ◽  
Chin Kook Rhee
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Interstitial Lung Disease ◽  
Pulmonary Fibrosis ◽  
Lung Disease ◽  
Pulmonary Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Quit Smoking ◽  
Lung Abnormalities ◽  
Pharmacologic Agents

Although chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) have distinct clinical features, both diseases may coexist in a patient because they share similar risk factors such as smoking, male sex, and old age. Patients with both emphysema in upper lung fields and diffuse ILD are diagnosed with combined pulmonary fibrosis and emphysema (CPFE), which causes substantial clinical deterioration. Patients with CPFE have higher mortality compared with patients who have COPD alone, but results have been inconclusive compared with patients who have idiopathic pulmonary fibrosis (IPF). Poor prognostic factors for CPFE include exacerbation, lung cancer, and pulmonary hypertension. The presence of interstitial lung abnormalities, which may be an early or mild form of ILD, is notable among patients with COPD, and is associated with poor prognosis. Various theories have been proposed regarding the pathophysiology of CPFE. Biomarker analyses have implied that this pathophysiology may be more closely associated with IPF development, rather than COPD or emphysema. Patients with CPFE should be advised to quit smoking and undergo routine lung function tests, and pulmonary rehabilitation may be helpful. Various pharmacologic agents may be beneficial in patients with CPFE, but further studies are needed.

scholarly journals Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies

2013 ◽  
Vol 107 (4) ◽  
pp. 580-586 ◽  
Author(s):  
Raul H. Sansores ◽  
Alejandra Ramírez-Venegas ◽  
Rafael Hernández-Zenteno ◽  
María Eugenia Mayar-Maya ◽  
Oliver G. Pérez-Bautista ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
At Risk ◽  
Comparative Study ◽  
Pulmonary Disease ◽  
Case Finding ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Screening Strategies

scholarly journals Evaluation of energy intake by brief-type self-administered diet history questionnaire among male patients with stable/at risk for chronic obstructive pulmonary disease

2021 ◽  
Vol 8 (1) ◽  
pp. e000807
Author(s):  
Yuki Nishida ◽  
Hidetoshi Nakamura ◽  
Satoshi Sasaki ◽  
Toru Shirahata ◽  
Hideaki Sato ◽  
...  
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
At Risk ◽  
Pulmonary Disease ◽  
Energy Intake ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Diet History Questionnaire ◽  
Diet History ◽  
Male Patients ◽  
The Difference

Background and objectiveWeight loss and reduced fat-free mass are independent risk factors for mortality among patients with chronic obstructive pulmonary disease (COPD). These factors are important for determining diet therapy and examining the validity of assessment for energy intake (EI). We assessed the agreement of EI between a brief-type self-administered diet history questionnaire (BDHQ) and the doubly labelled water (DLW) method among male patients with stable/at risk for COPD.MethodIn this cross-sectional observational study, data for 33 male patients were analysed. At the first visit, EI was estimated using a BDHQ (EIBDHQ). Total energy expenditure (TEE) was measured during 13–15 days by the DLW method, while corrected EI was calculated using the TEE and weight change during the DLW period (EIDLW). The difference between EIBDHQ and EIDLW was evaluated by the Bland-Altman method. Multiple regression analysis was used to determine the proportion of variance in the difference between EIBDHQ and EIDLW, as determined by the patient’s characteristics.ResultsEIBDHQ was 2100 (95% CI: 1905 to 2295) kcal/day in the total population. A fixed bias was observed between EIBDHQ and EIDLW as −186 (95% CI: −422 to 50) kcal/day, while a proportional bias was not detected by the Bland-Altman analysis. Age, weight, anxiety and interleukin 6 were responsible for 61.7% of the variance in the difference between both EIs in a multiple regression model.ConclusionsThe BDHQ underestimated EI among male patients with stable/at risk for COPD, but this estimation error was within an acceptable range compared with previous studies. EIBDHQ precision might be improved by considering common COPD traits, including inflammatory condition and mental state.

Sign in / Sign up

Export Citation Format

Share Document